People
Pfizer Chief Executive Officer Albert Bourla tapped Aamir Malik to serve as the company’s chief business innovation officer.
BioSpace recently spoke with Yoav Kimchy, founder and chief technology officer of Check-Cap, a company developing the C-Scan® system to detect precancerous polyps.
Anti-aging organization SENS Research Foundation sacked Chief Science Officer Aubrey de Grey over concerns he has attempted to influence an investigation of sexual harassment claims filed against him.
David Sabatini had initially been suspended from his position, but following the conclusion of the investigation, he was terminated over the weekend.
Woodcock faces heavy opposition from an evenly divided U.S. Senate, particularly from West Virginia Sen. Joe Manchin, who has been critical of the approval process for Biogen’s Aduhelm, formerly known as aducanumab.
The passing of the baton was announced late Thursday. Duato will take over as CEO on Jan. 3, 2022.
Cerner has appointed former Google Health boss David Feinberg as its new chief executive and president effective October 1, 2021.
Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.
The latest biopharma insider trading scandal stems from Pfizer’s acquisition of Medivation in 2016.
Two months after Athira placed its CEO Leen Kawas, on temporary leave, the company has appointed new execs to its team. It is also rigorously advancing its Alzheimer’s program.
PRESS RELEASES